⌘K
E
Endovascular Engineering
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$42M
Endovascular Engineering, Inc. develops the Hēlo Thrombectomy System, a novel technology for removing clots in venous thromboembolism (VTE).
Focus Areas
Medical technology
Clot removal
Thrombectomy system
Venous thromboembolism
Healthcare innovation
Investors
